Bank of America Global Healthcare Conference 2026 May 12, 2026 7:20 PM EDTCompany ParticipantsMegan Sniecinski ...

Jay Bhattacharya dismissed the test-negative design as 'crap.' The biostatistics literature tells a different story.

Recent progress in the treatment of advanced urothelial carcinoma (UC) has improved the outlook for patients with metastatic disease. However, UC in the earlier stages remains a major source of ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...

Abstract: This paper utilizes parallel control to investigate the problem of event-triggered deep reinforcement learning and develops an event-triggered deep Q-network (ETDQN) for decision-making of ...

Low fruit intake is a global risk factor for cardiometabolic diseases. This study sought to investigate vascular and metabolic effects of increasing total and select fruit intake in adults with ...

3 The Affiliated Guangzhou Hospital of TCM of Guangzhou University of Chinese Medicine, Guangzhou, China 4 The Affiliated Brain Hospital, Guangzhou Medical University, Key Laboratory of Neurogenetics ...

Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study This randomized, parallel-group, phase II study ...

Parking is not always an easy task. Sometimes spots are too tight, too small or positioned strangely — not to mention the potential obstacles hindering your perfect parking, like other vehicles, trees ...

Nov 12 (Reuters) - AI startup Parallel Web Systems, founded by former Twitter CEO Parag Agrawal, has raised $100 million to build web search infrastructure for artificial intelligence agents and fund ...

We performed a meta-analysis and dose-response analysis to explore the relationship between magnesium supplementation and BP in randomized-controlled trials with a duration of ≥4 weeks, using a cubic ...

Good afternoon, and welcome to TD Cowen's Neuropsych Summit. I'm Phil Nadeau, one of the biotech analysts here at TD Cowen, and it's my pleasure to moderate a fireside chat with Neurocrine Biosciences ...